Tenax Therapeutics Inc. buy melinda
Summary
This prediction ended on 23.01.19 with a price of €21.65. Massive losses of -77.61% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Tenax Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -3.033% | 0.651% | 12.268% | 18.187% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% | 47.279% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% | 10.489% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% | 45.572% |
Comments by melinda for this prediction
In the thread Tenax Therapeutics Inc. diskutieren
SecteurRecherche biotechnologique et médicale Agenda 08/11 Publication de résultats
Métier
Logo Tenax Therapeutics IncDiscovers, develops and commercializes novel therapeutic products
Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and commercializing novel therapeutic products for the critical care market.
Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure.
The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.
Nombre d'employés : 8 personnes
Stopped prediction by melinda for Tenax Therapeutics Inc.
Tenax Therapeutics Inc.
18.10.22
18.10.23
19.10.23
Tenax Therapeutics Inc.
13.12.20
13.12.21
14.12.21
Tenax Therapeutics Inc.
25.08.20
04.11.21
13.12.20
Tenax Therapeutics Inc.
03.02.17
03.08.17
03.08.17
Tenax Therapeutics Inc.
14.06.10
15.12.10
15.12.10